{"blog": [], "keywords": [{"value": "Breast Cancer", "name": "subject", "rank": "1", "is_major": "Y"}, {"value": "Chemotherapy", "name": "subject", "rank": "2", "is_major": "Y"}, {"value": "New England Journal of Medicine", "name": "organizations", "rank": "3", "is_major": "Y"}, {"value": "Cardoso, Fatima", "name": "persons", "rank": "4", "is_major": "N"}, {"value": "Tests (Medical)", "name": "subject", "rank": "5", "is_major": "N"}, {"value": "Genetics and Heredity", "name": "subject", "rank": "6", "is_major": "N"}, {"value": "Women and Girls", "name": "subject", "rank": "7", "is_major": "N"}], "web_url": "http://www.nytimes.com/2016/08/25/science/gene-tests-identify-breast-cancer-patients-who-can-skip-chemotherapy-study-says.html", "document_type": "article", "byline": {"person": [{"lastname": "GRADY", "firstname": "Denise", "role": "reported", "organization": "", "rank": 1}], "original": "By DENISE GRADY"}, "type_of_material": "News", "multimedia": [{"url": "images/2016/08/25/science/24CANCER5/24CANCER5-thumbWide.jpg", "legacy": {"wide": "images/2016/08/25/science/24CANCER5/24CANCER5-thumbWide.jpg", "wideheight": "126", "widewidth": "190"}, "subtype": "wide", "type": "image", "width": 190, "height": 126}, {"url": "images/2016/08/25/science/24CANCER5/24CANCER5-articleLarge.jpg", "legacy": {"xlarge": "images/2016/08/25/science/24CANCER5/24CANCER5-articleLarge.jpg", "xlargeheight": "564", "xlargewidth": "600"}, "subtype": "xlarge", "type": "image", "width": 600, "height": 564}, {"url": "images/2016/08/25/science/24CANCER5/24CANCER5-thumbStandard.jpg", "legacy": {"thumbnail": "images/2016/08/25/science/24CANCER5/24CANCER5-thumbStandard.jpg", "thumbnailheight": "75", "thumbnailwidth": "75"}, "subtype": "thumbnail", "type": "image", "width": 75, "height": 75}], "section_name": "Science", "word_count": "1225", "source": "The New York Times", "subsection_name": null, "lead_paragraph": "Researchers found that nearly half of women with early breast cancer can safely avoid the treatment with little risk of cancer recurring or spreading in five years.", "pub_date": "2016-08-25T04:00:00+0000", "news_desk": "National", "headline": {"print_headline": "Gene Tests Identify Breast Cancer Patients Who Can Skip Chemo, Study Says", "main": "Gene Tests Identify Breast Cancer Patients Who Can Skip Chemotherapy, Study Says"}, "print_page": "10", "snippet": "Researchers found that nearly half of women with early breast cancer can safely avoid the treatment with little risk of cancer recurring or spreading in five years....", "_id": "57be306a95d0e021d798271a", "slideshow_credits": null, "abstract": "Study published in New England Journal of Medicine finds nearly half of women with early-stage breast cancer can skip chemotherapy with little risk of recurrence; researchers say by measuring activity of genes controlling growth and spread of cancer--so-called genome test--they can determine which patients would not benefit from chemo; findings reassure doctors who want to spare patients treatment's harsh side effects, although patients who skip chemo have slightly higher disease recurrence rates."}